Nifty
:
24579.60
Sensex
:
80157.88
-45.45 (-0.18%)
-206.61 (-0.26%)
Nifty
Sensex
:
:
24579.60
80157.88
-45.45 (-0.18%)
-206.61 (-0.26%)

Indoco Remedies Ltd.

Pharmaceuticals & Drugs - Global

Rating :
38/99

BSE: 532612 | NSE: INDOCO

NSE BSE
275.70
02-Sep-2025
  • Open
  • High
  • Low
  • Previous Close
  •  265.9
  •  277.95
  •  265.9
  •  267.90
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  17645
  •  4847932.95
  •  387.55
  •  190

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 2,553.88
  • N/A
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 3,514.85
  • 0.07%
  • 2.61

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 58.90%
  • 2.44%
  • 15.78%
  • FII
  • DII
  • Others
  • 1.22%
  • 18.55%
  • 3.11%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 5.14
  • 6.04
  • -0.07

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -5.12
  • -14.59
  • -19.08

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 29.55
  • 28.56
  • 22.92

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 3.21
  • 3.43
  • 2.91

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 16.81
  • 15.95
  • 16.68

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 25
Jun 24
Var%
Mar 25
Mar 24
Var%
Dec 24
Dec 23
Var%
Sep 24
Sep 23
Var%
Net Sales
437.89
431.49
1.48%
390.21
449.64
-13.22%
410.55
459.42
-10.64%
432.66
481.73
-10.19%
Expenses
420.36
383.72
9.55%
390.99
400.77
-2.44%
398.52
396.52
0.50%
392.41
410.36
-4.37%
EBITDA
17.53
47.77
-63.30%
-0.78
48.87
-
12.03
62.90
-80.87%
40.25
71.37
-43.60%
EBIDTM
4.00%
11.07%
-0.20%
10.87%
2.93%
13.69%
9.30%
14.82%
Other Income
1.63
1.03
58.25%
2.02
2.66
-24.06%
0.85
2.35
-63.83%
1.56
4.43
-64.79%
Interest
26.12
14.31
82.53%
17.98
12.05
49.21%
16.11
10.07
59.98%
17.83
8.11
119.85%
Depreciation
29.70
27.52
7.92%
28.78
26.23
9.72%
28.72
24.35
17.95%
28.82
21.41
34.61%
PBT
-36.66
6.97
-
-45.52
32.98
-
-30.96
22.63
-
-4.84
46.28
-
Tax
-0.31
5.15
-
-4.18
10.95
-
-2.56
7.07
-
5.17
11.04
-53.17%
PAT
-36.35
1.82
-
-41.34
22.03
-
-28.40
15.56
-
-10.01
35.24
-
PATM
-8.30%
0.42%
-10.59%
4.90%
-6.92%
3.39%
-2.31%
7.32%
EPS
-3.88
0.29
-
-4.38
2.46
-
-2.86
1.77
-
-1.04
3.81
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Net Sales
1,671.31
1,664.92
1,817.29
1,668.61
1,540.75
1,241.53
1,106.58
968.45
1,041.94
1,074.77
1,008.12
Net Sales Growth
-8.28%
-8.38%
8.91%
8.30%
24.10%
12.20%
14.26%
-7.05%
-3.05%
6.61%
 
Cost Of Goods Sold
491.66
498.18
559.18
521.29
456.79
354.10
330.43
320.25
347.83
361.27
350.01
Gross Profit
1,179.65
1,166.73
1,258.10
1,147.32
1,083.97
887.42
776.15
648.19
694.11
713.49
658.12
GP Margin
70.58%
70.08%
69.23%
68.76%
70.35%
71.48%
70.14%
66.93%
66.62%
66.39%
65.28%
Total Expenditure
1,602.28
1,565.67
1,580.87
1,382.57
1,214.50
1,023.20
985.74
891.80
910.37
920.27
840.17
Power & Fuel Cost
-
59.61
56.00
50.61
42.78
36.89
34.75
28.49
26.62
23.12
21.72
% Of Sales
-
3.58%
3.08%
3.03%
2.78%
2.97%
3.14%
2.94%
2.55%
2.15%
2.15%
Employee Cost
-
394.05
361.93
322.58
296.28
274.02
256.51
231.66
220.91
216.67
181.87
% Of Sales
-
23.67%
19.92%
19.33%
19.23%
22.07%
23.18%
23.92%
21.20%
20.16%
18.04%
Manufacturing Exp.
-
214.28
247.42
195.91
184.62
130.32
114.63
107.07
101.94
96.38
85.18
% Of Sales
-
12.87%
13.61%
11.74%
11.98%
10.50%
10.36%
11.06%
9.78%
8.97%
8.45%
General & Admin Exp.
-
152.02
137.54
121.88
106.75
97.57
127.76
110.92
110.04
116.40
102.56
% Of Sales
-
9.13%
7.57%
7.30%
6.93%
7.86%
11.55%
11.45%
10.56%
10.83%
10.17%
Selling & Distn. Exp.
-
189.69
149.45
111.33
83.19
76.02
89.28
62.75
70.53
73.22
55.89
% Of Sales
-
11.39%
8.22%
6.67%
5.40%
6.12%
8.07%
6.48%
6.77%
6.81%
5.54%
Miscellaneous Exp.
-
57.83
69.34
58.95
44.10
54.28
32.38
30.66
32.49
33.20
55.89
% Of Sales
-
3.47%
3.82%
3.53%
2.86%
4.37%
2.93%
3.17%
3.12%
3.09%
4.26%
EBITDA
69.03
99.25
236.42
286.04
326.25
218.33
120.84
76.65
131.57
154.50
167.95
EBITDA Margin
4.13%
5.96%
13.01%
17.14%
21.17%
17.59%
10.92%
7.91%
12.63%
14.38%
16.66%
Other Income
6.06
5.45
18.72
2.63
3.42
9.06
4.80
6.70
8.05
5.93
4.03
Interest
78.04
66.23
39.01
25.27
14.14
22.26
26.25
21.09
23.51
6.21
12.39
Depreciation
116.02
113.84
91.87
70.61
78.96
73.13
70.82
71.57
67.71
63.28
60.66
PBT
-117.98
-75.36
124.27
192.79
236.57
132.00
28.57
-9.31
48.40
90.94
98.93
Tax
-1.88
3.58
38.79
50.54
81.77
38.95
4.45
-6.41
7.24
13.87
16.99
Tax Rate
1.59%
-4.81%
28.56%
26.22%
34.56%
29.51%
15.58%
68.85%
14.96%
15.25%
17.17%
PAT
-116.10
-73.74
98.46
142.25
154.80
93.05
24.12
-2.90
41.16
77.06
81.94
PAT before Minority Interest
-112.14
-77.95
97.00
142.25
154.80
93.05
24.12
-2.90
41.16
77.06
81.94
Minority Interest
3.96
4.21
1.46
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
-6.95%
-4.43%
5.42%
8.53%
10.05%
7.49%
2.18%
-0.30%
3.95%
7.17%
8.13%
PAT Growth
-255.53%
-
-30.78%
-8.11%
66.36%
285.78%
-
-
-46.59%
-5.96%
 
EPS
-12.59
-8.00
10.68
15.43
16.79
10.09
2.62
-0.31
4.46
8.36
8.89

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Shareholder's Funds
1,022.00
1,109.90
1,028.25
904.64
768.99
679.57
660.62
674.98
651.34
576.52
Share Capital
18.45
18.44
18.43
18.43
18.43
18.43
18.43
18.43
18.43
18.43
Total Reserves
997.81
1,087.93
1,009.16
886.21
750.56
661.14
642.19
656.55
632.91
558.08
Non-Current Liabilities
603.54
421.90
205.44
156.60
158.36
101.00
116.42
125.34
147.04
66.28
Secured Loans
533.20
351.73
143.50
95.88
96.94
96.93
128.66
123.28
132.31
34.24
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
3.64
Long Term Provisions
35.82
33.68
33.40
31.74
66.35
27.14
15.95
23.77
30.91
40.63
Current Liabilities
808.47
645.50
480.79
518.16
406.92
458.99
445.50
417.36
390.39
302.95
Trade Payables
208.13
153.64
123.46
133.29
113.23
165.60
170.72
149.55
164.03
131.31
Other Current Liabilities
192.71
149.80
132.06
139.61
129.48
135.81
117.13
119.66
72.16
57.38
Short Term Borrowings
362.01
260.52
119.45
103.73
117.31
105.98
113.39
109.93
118.36
87.23
Short Term Provisions
45.62
81.53
105.82
141.53
46.91
51.59
44.26
38.22
35.84
27.03
Total Liabilities
2,430.39
2,177.90
1,714.48
1,579.40
1,334.27
1,239.56
1,222.54
1,217.68
1,188.77
945.75
Net Block
996.88
954.29
678.25
555.10
569.94
589.74
467.65
488.86
439.89
373.64
Gross Block
1,927.60
1,780.68
1,422.93
1,236.19
1,177.74
1,126.76
934.65
885.11
769.65
641.95
Accumulated Depreciation
930.72
826.39
744.68
681.09
607.80
537.02
467.00
396.25
329.75
268.32
Non Current Assets
1,428.58
1,190.06
844.63
712.47
711.75
676.45
684.49
678.73
616.72
481.20
Capital Work in Progress
320.54
124.81
113.60
121.53
68.19
50.70
185.43
135.56
90.63
54.80
Non Current Investment
1.46
1.46
1.46
0.02
0.02
0.02
0.02
0.02
0.02
0.02
Long Term Loans & Adv.
102.75
102.45
49.06
25.99
64.01
26.16
22.01
33.92
66.46
48.15
Other Non Current Assets
6.94
7.04
2.26
9.83
9.59
9.83
9.38
20.36
19.72
4.60
Current Assets
1,001.81
987.84
869.85
866.92
622.53
563.10
538.05
538.96
572.05
464.55
Current Investments
0.00
7.24
1.00
0.00
0.00
0.00
0.00
0.00
0.00
15.68
Inventories
419.35
353.06
325.99
310.52
237.85
208.32
183.45
193.38
186.94
166.69
Sundry Debtors
352.41
406.20
350.94
297.25
233.82
210.14
195.84
209.51
215.68
188.83
Cash & Bank
17.07
24.32
13.34
19.77
14.34
37.93
36.26
11.90
62.59
12.63
Other Current Assets
212.98
42.23
20.18
34.59
136.52
106.71
122.51
124.17
106.85
80.72
Short Term Loans & Adv.
167.48
154.78
158.41
204.80
124.62
97.60
106.96
117.71
89.21
72.06
Net Current Assets
193.34
342.34
389.06
348.77
215.61
104.12
92.55
121.60
181.66
161.60
Total Assets
2,430.39
2,177.90
1,714.48
1,579.39
1,334.28
1,239.55
1,222.54
1,217.69
1,188.77
945.75

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Cash From Operating Activity
94.93
155.39
178.83
173.83
82.22
122.85
132.11
122.72
88.64
113.34
PBT
-75.36
124.27
192.79
236.57
132.00
28.57
-9.31
48.40
90.94
100.58
Adjustment
183.64
137.55
120.88
87.12
109.76
99.51
89.35
97.67
64.60
76.29
Changes in Working Capital
2.78
-88.47
-73.19
-108.79
-139.81
-1.49
55.62
-13.23
-43.25
-36.12
Cash after chg. in Working capital
111.06
173.35
240.48
214.91
101.94
126.60
135.66
132.83
112.29
140.75
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-17.12
-29.49
-61.65
-41.08
-19.72
-3.75
-3.55
-10.12
-23.65
-27.41
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.99
11.53
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-339.11
-432.52
-208.17
-121.41
-66.69
-55.93
-103.76
-135.43
-170.55
-111.96
Net Fixed Assets
-222.13
-150.58
-161.10
-111.78
-68.48
-57.37
-99.41
-160.40
-163.74
-86.39
Net Investments
7.24
-39.30
-17.44
-0.01
0.00
-0.01
0.17
0.21
15.47
-17.65
Others
-124.22
-242.64
-29.63
-9.62
1.79
1.45
-4.52
24.76
-22.28
-7.92
Cash from Financing Activity
241.42
280.43
22.80
-44.37
-29.87
-63.95
-16.14
-38.77
131.57
-1.48
Net Cash Inflow / Outflow
-2.76
3.31
-6.54
8.05
-14.34
2.97
12.22
-51.48
49.66
-0.11
Opening Cash & Equivalents
14.86
10.92
17.47
9.42
23.76
20.80
8.58
60.06
10.40
10.47
Closing Cash & Equivalent
12.10
14.86
10.92
17.47
9.42
23.76
20.80
8.58
60.06
10.36

Financial Ratios

Consolidated /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Book Value (Rs.)
110.17
120.02
111.51
98.17
83.45
73.75
71.69
73.25
70.68
62.56
ROA
-3.38%
4.98%
8.64%
10.63%
7.23%
1.96%
-0.24%
3.42%
7.22%
9.15%
ROE
-7.34%
9.09%
14.72%
18.50%
12.85%
3.60%
-0.43%
6.21%
12.55%
14.96%
ROCE
-0.43%
11.25%
17.50%
23.03%
15.67%
5.78%
1.23%
7.62%
11.80%
16.72%
Fixed Asset Turnover
0.90
1.13
1.25
1.28
1.08
1.07
1.06
1.26
1.55
1.69
Receivable days
83.16
76.04
70.89
62.90
65.26
66.96
76.39
74.23
67.31
62.31
Inventory Days
84.67
68.19
69.62
64.95
65.58
64.61
71.01
66.40
58.84
57.17
Payable days
132.53
90.44
89.88
98.49
143.70
67.82
71.91
66.57
61.79
56.58
Cash Conversion Cycle
35.30
53.79
50.63
29.37
-12.86
63.74
75.49
74.06
64.37
62.91
Total Debt/Equity
0.96
0.59
0.31
0.27
0.34
0.39
0.45
0.42
0.43
0.24
Interest Cover
-0.12
4.48
8.63
17.73
6.93
2.09
0.56
3.06
15.64
8.98

Annual Reports:

FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016

News Update:


  • Indoco Remedies gets final nod for Rivaroxaban Tablets
    13th Aug 2025, 12:00 PM

    Rivaroxaban is used for the treatment of venous thromboembolism

    Read More
  • Indoco Remedies - Quarterly Results
    24th Jul 2025, 12:02 PM

    Read More
  • Indoco Remedies gets Certificate of EU GMP Compliance for sterile drug product manufacturing facility in Goa
    24th Jul 2025, 10:21 AM

    The company remains fully committed to adhering to cGMP standards and consistently delivering quality products to customers and patients worldwide

    Read More
  • Indoco Remedies’ arm launches Ticagrelor film-coated tablets in UK
    3rd Jun 2025, 15:21 PM

    Ticagrelor film-coated tablets are indicated to reduce the chances of heart attack, stroke, myocardial infarction (MI) or diseases related to the heart or blood vessels

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.